Pharma Global

Singapore, Indonesia

Pharma Global is a company that introduces BigData and AI technologies into the healthcare sphere and supply chain in pharma. There are 3 main products and solutions: 1) Educational platform PharmaCourse (Pharmznanie in the Russian/CIS markets). This solution allows pharmacists to improve their skills remotely and without interruption from work (both mandatory and voluntary education). 2) PharmaMarket - a marketplace, where pharmaceutical companies get direct access to pharmacies and are able to make direct marketing and sales contracts. 3)PharmaBonus (Cash back from pharmacies in Russia). A cash back service for final customers of the pharmacies to analyse the final pharmacy sales The company has approved the technology in the Russian and CIS markets since 2016th and now became a leader in Russia in the market of postgraduate education for healthcare specialists (holding 16% of market), and also occupies about 10% of the pharmaceutical retail in the direct contracts between pharmacy retail and pharmaceutical companies In 2019 the company has started launching its services in the MENA region being based in the UAE. The main value is to increase the clearence m of the pharmaceutical market in the Middle East and to attract pharmaceutical manufactures in the region Key figures are as follows: a) 105+ pharmaceutical companies as clients b) 21, 368 pharmacies onboarded c) 68,319 healthcare specialists are in network

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Pharma Global on @MedStartr Today #MedMo #MedStartrVentures

https://www.medstartr.ai/s/SUg8gS0VDgY

Get Involved in Pharma Global

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: www.gblpharma.com/

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Pharma Global?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.

Get Involved in Pharma Global